TITLE

Meta-analysis of clinical outcomes of maze-related surgical procedures for medically refractory atrial fibrillation

AUTHOR(S)
Reston, James T.; Shuhaiber, Jeffrey H.
PUB. DATE
November 2005
SOURCE
European Journal of Cardio-Thoracic Surgery;Nov2005, Vol. 28 Issue 5, p724
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract: Objective: Although maze-related surgical procedures have shown success at eliminating atrial fibrillation, published controlled studies have generally been too small to detect clinically significant differences in morbidity and mortality. We pooled available studies to determine whether a simultaneous maze procedure reduces the risk of stroke or death in patients with chronic or paroxysmal atrial fibrillation who receive mitral valve surgery. Secondary outcomes included post-operative bleeding and need for pacemaker. Methods: Our systematic review identified four randomized controlled trials and six retrospective comparative studies that met minimum quality criteria. We conducted meta-analyses of clinical outcomes using Cohen''s h, a statistic appropriate for analysis of infrequent events. Results: The findings suggest that maze may reduce stroke risk but also increase the need for pacemaker implantation, as well as increase the risk of post-operative bleeding unless radiofrequency ablation is used. However, the statistically significant findings for stroke, need for pacemaker, and post-operative bleeding were overturned by sensitivity analysis, indicating that the findings are not robust. Conclusion: The literature evaluating maze clinical outcomes suffers from several shortcomings, particularly small sample sizes and selection bias. However, weak evidence supports a reduction in stroke rates and an increase in need for pacemakers among patients receiving the maze procedure. Radiofrequency maze may avoid an excess risk of post-operative bleeding associated with maze incisions. Larger, well-designed RCTs are needed to confirm these findings and evaluate outcomes such as survival and quality of life.
ACCESSION #
18965406

 

Related Articles

  • A Clinical Profile of Idiopathic Atrial Fibrillation. Peter, Robert H.; Gracey, Jack G.; Beach, Thomas B. // Annals of Internal Medicine;Jun68, Vol. 68 Issue 6, p1288 

    Presents information on a study which observed patients with idiopathic atrial fibrillation. Methodology; Results; Discussion.

  • HOSPITALIZATONS FOR IRREGULAR HEART BEAT ON THE INCREASE.  // Mind, Mood & Memory;Aug2014, Vol. 10 Issue 8, p1 

    The article focuses on the increased number of hospitalizations for patients with a heart rhythm disorder or atrial fibrillation which is attributed to an increase in the prevalence of risk factors such as high blood pressure, lung disease, and sleep apnea in the population.

  • Warfarin.  // Reactions Weekly;12/1/2007, Issue 1180, p38 

    The article describes the case of an 84-year-old man who developed a possible case of "purple toe" syndrome following warfarin therapy for atrial fibrillation. The patient's toes were painful and had turned purple. Prior to a dental procedure, warfarin was withheld and his symptoms were...

  • Dabigatran vs warfarin: Less bleeding?  // Clinical Cardiology Alert;Nov2009 Clinical Briefs, p21 

    The article discusses research on the efficacy of dabigatran (DAB) and warfarin (WRF) against bleeding in patients with atrial fibrillation (AF). It references a study by S. J. Connolly et al published in a 2009 issue of the "New England Journal of Medicine." According to the study, DAB can be...

  • Dabigatran vs warfarin: Less bleeding? Kuritzky, Louis // Neurology Alert;Nov2009 Primary Care, p21 

    The article discusses research on the efficacy of dabigatran (DAB) and warfarin (WRF) against bleeding in patients with atrial fibrillation (AF). It references a study by S. J. Connolly et al published in a 2009 issue of the "New England Journal of Medicine." According to the study, of DAB can...

  • Older patients losing out on AF treatment.  // GP: General Practitioner;9/8/2006, p8 

    The article presents information on Euro Heart Survey, a survey on atrial fibrillation (AF). The study found out that younger patients were prone to be treated according mentioned guidelines. Professor Robby Nieuwlaat, from the University Hospital Maastricht informed that patients with AF very...

  • Dabigatran vs warfarin: Less bleeding? Kuritzky, Louis // Primary Care Reports;Nov2009 Primary Care, p21 

    The article discusses research on the efficacy of dabigatran (DAB) and warfarin (WRF) against bleeding in patients with atrial fibrillation (AF). It references a study by S. J. Connolly et al published in a 2009 issue of the "New England Journal of Medicine." According to the study, DAB can be...

  • Dabigatran vs warfarin: Less bleeding?  // Clinical Oncology Alert;Nov2009 Supplement, p21 

    The article discusses research on the efficacy of dabigatran (DAB) and warfarin (WRF) against bleeding in patients with atrial fibrillation (AF). It references a study by S. J. Connolly et al published in a 2009 issue of the "New England Journal of Medicine." According to the study, DAB can be...

  • Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation. Lee, Soyon; Mullin, Rachel; Blazawski, Jon; Coleman, Craig I. // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Background: Apixaban was shown to be superior to adjusted-dose warfarin in preventing stroke or systemic embolism in patients with atrial fibrillation (AF) and at least one additional risk factor for stroke, and associated with reduced rates of hemorrhage. We sought to determine the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics